Hormonal Changes in Women with Epilepsy
Qiwei Li,Zhiyun Zhang,Jiajia Fang
DOI: https://doi.org/10.2147/ndt.s453532
IF: 2.989
2024-02-27
Neuropsychiatric Disease and Treatment
Abstract:Qiwei Li, 1 Zhiyun Zhang, 1, 2 Jiajia Fang 1 1 Department of Neurology, The Fourth Affiliated Hospital, International Institutes of Medicine, Zhejiang University School of Medicine, Yiwu, Zhejiang Province, 322000, People's Republic of China; 2 Department of Neurology, The Mianyang Central Hospital, Mianyang, Sichuan Province, 621000, People's Republic of China Correspondence: Jiajia Fang, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, People's Republic of China, Email Epilepsy is a prevalent neurological disorder among women globally, often requiring long-term treatment. Hormonal fluctuations in women with epilepsy (WWE) can have reciprocal effects on epilepsy and antiseizure medications (ASMs), posing significant challenges for WWE. Notably, WWE commonly experience endocrine alterations such as thyroid dysfunctions, low bone metabolism, and reproductive hormone irregularities. On the one hand, the presence of hormones in women with epilepsy affects their susceptibility to epilepsy as well as the metabolism of antiseizure medications in various ways. On the other hand, epilepsy itself and the use of antiseizure medications impact the production, secretion, and metabolism of hormones, resulting in low fertility, increased risk of pregnancy complications, negative offspring outcomes, and so on. In order to develop more precise treatment strategies in the future, it is necessary to comprehend the explicit relationships between hormones, epilepsy, and antiseizure medications, as well as to elucidate the currently known mechanisms underlying these interactions. Keywords: women with epilepsy, antiseizure medications, endocrine, hormonal changes Epilepsy is a prevalent chronic neurological disorder on a global scale, with an estimated lifetime prevalence of 7.60 cases per 1000 individuals. 1 In the context of gender, the affliction affects approximately 6.85 cases per 1000 women, 1 suggesting that fewer women endure the pain of illness compared to men. However, due to the dynamic nature of hormonal changes throughout the lifespan of women, coupled with the impact of epilepsy and the metabolism of antiseizure medications (ASMs), which presents a significant challenge arises for women, gynecologists, and neurologists. Research has indicated that women with epilepsy (WWE) have a higher propensity for developing metabolic or hormonal irregularities compared to their healthy counterparts of similar age, 2 eg, the prevalence of polycystic ovary syndrome (PCOs) in women with endocrine disorders (WWE) is estimated to be around 10–25%, whereas in the general population, it varies between 8% and 13% due to variations in diagnostic criteria and ethnic disparities. 3 In this review, we delve into the endocrine aberrations encompassing thyroid hormones, bone metabolism, and sex hormones, elucidating their enduring repercussions on women, their fetuses during gestation, and subsequent stages of life ( Figure S1 ). This comprehensive analysis scrutinizes the available evidence pertaining to the matter of endocrine dysfunctions in WWE with endocrine disorders, while also highlighting the necessary actions to be undertaken in the forthcoming period. Thyroid hormones (THs) are crucial for regulating energy metabolism and central nervous system (CNS) development. 4 The synthesis and release of THs are controlled by the hypothalamic–pituitary–thyroid (HPT) axis, primarily through thyroid stimulating hormone (TSH) and thyrotropin-releasing hormone (TRH) negative feedback regulation. While the impact of thyroid hormone abnormalities in epilepsy patients has been extensively discussed, previous research has primarily focused on the relationship between ASMs and thyroid hormones. A comprehensive analysis comprising forty-seven studies investigating the relationship between epilepsy and thyroid hormone metabolism reveals that nearly one-third of patients with epilepsy (PWE) encountered fluctuations in thyroid hormone levels. 5 The existing literature on the impact of thyroid hormones specifically on WWE remains scarce and inconclusive. The maintenance of optimal thyroid hormone homeostasis is crucial for the proper development and stability of CNS starting from the early stages of fetal life. 6 THs play a significant role in various processes such as neurogenesis, angiogenesis, and neuronal plasticity. Specifically, triiodothyronine (T3) regulates the activities of Cajal-Retzius and subplate cells, which are involved in axon routing, cell migration, and the stratification of the cerebral cortex. 7 Furthermore, it has been observed that the regulation of extracellular matrix protein synthesis is directly THs, which in turn has been linked to a decre -Abstract Truncated-
psychiatry,clinical neurology